Atlas Trials

Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis

Clinical trial NCT03006809 · COMPLETED

Trial details

NCT number
NCT03006809
Sponsor
Najwa Elnachef
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2017-03-02
Primary completion
2020-05-04
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.